Insulet Corp.Financials
|
|
Insulet Corp. (PODD) financial statements from SEC filings: income statement, balance sheet and cash flow, by year and quarter.
Historical Financials
DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | DEC 2019 | DEC 2018 | DEC 2017 | DEC 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,708,100,000 | 2,071,600,000 | 1,697,100,000 | 1,305,300,000 | 1,098,800,000 | 904,400,000 | 738,200,000 | 563,800,000 | 463,768,000 | 366,989,000 | |
| Cost of Revenue | 768,200,000 | 625,900,000 | 537,200,000 | 499,700,000 | 346,700,000 | 322,100,000 | 257,900,000 | 193,600,000 | 186,600,000 | 155,903,000 | |
| Gross Profit | 1,939,900,000 | 1,445,700,000 | 1,159,900,000 | 805,600,000 | 752,100,000 | 582,300,000 | 480,300,000 | 370,200,000 | 277,200,000 | 211,086,000 |
Sign up to view full financial statements
Create a free CapEdge account to access balance sheet, cash flow, and complete historical data.
DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | DEC 2019 | DEC 2018 | DEC 2017 | DEC 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin (%) | |||||||||||
| R&D Expense | |||||||||||
| SG&A Expense | |||||||||||
| Total Operating Expenses | |||||||||||
| Operating Income or Loss | |||||||||||
| Operating Margin (%) | |||||||||||
| EBITDA | |||||||||||
| Interest Expense | |||||||||||
| Non-Operating Income/Expense | |||||||||||
| Income Before Tax | |||||||||||
| Income Tax Expense | |||||||||||
| Income from Continuing Ops. | |||||||||||
| Net Income | |||||||||||
| Net Profit Margin (%) | |||||||||||
| Basic EPS | |||||||||||
| Diluted EPS | |||||||||||
| Basic Average Shares | |||||||||||
| Diluted Average Shares |
All numbers in thousands. Financial statements are in beta and sourced from EDGAR XBRL filings. Read the caveats.